Trump’s big shift in drug policy: Expands access to marijuana, eases research restrictions

U.S. President Donald Trump signed an order recommending the loosening of federal regulations on marijuana, signaling a major shift away from past strict anti-cannabis policies. The directive instructs the attorney general to move quickly to reclassify marijuana, potentially placing it in a lower-risk category alongside substances such as common painkillers, ketamine, and testosterone, and opening the door to broader medical and regulatory changes in the United States.​